Cargando…
“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study
There has been a large global outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), representing a major public health issue. In China, combination therapy, including traditional Chinese medicine (TCM) as a treatment for COVID-19 has...
Autores principales: | Ai, Zhongzhu, Zhou, Shanshan, Li, Weinan, Wang, Mengfan, Wang, Linqun, Hu, Gangming, Tao, Ran, Wang, Xiaoqin, Shen, Yinfeng, Xie, Lihan, Ba, Yuanming, Wu, Hezhen, Yang, YanFang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580177/ https://www.ncbi.nlm.nih.gov/pubmed/33132913 http://dx.doi.org/10.3389/fphar.2020.581277 |
Ejemplares similares
-
Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge
por: Shen, Yinfeng, et al.
Publicado: (2021) -
Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
por: Zhou, Shanshan, et al.
Publicado: (2020) -
Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial
por: Li, Weinan, et al.
Publicado: (2023) -
Bu-Fei-Huo-Xue capsule alleviates bleomycin-induced pulmonary fibrosis in mice through modulating gut microbiota
por: Hu, Haibo, et al.
Publicado: (2023) -
Activation of Autophagy Through the NLRP3/mTOR Pathway: A Potential Mechanism for Alleviation of Pneumonia by QingFei Yin
por: Sun, Xiaozhou, et al.
Publicado: (2022)